AI Article Synopsis
- Cancer-associated thrombosis (CAT) is a frequent issue for cancer patients, increasing the risk of both blood clots and bleeding during anticoagulation treatment.
- In Taiwan, there's a perception of lower CAT incidence, which might give a false sense of security to patients and can impact their management.
- To address this, healthcare professionals in Taiwan are developing consensus guidelines for CAT management, focusing on local practices and integrating international guidelines to improve patient care.
Article Abstract
Cancer-associated thrombosis (CAT) is a common complication of malignancies. Patients with CAT are at risk of venous thromboembolism recurrence, but also at risk of bleeding while anticoagulated. Taiwanese patients are perceived to have a lower incidence of CAT, likely leading to false reassurance for Taiwanese patients with cancer. Because of this, oncologists and cardiologists from multiple medical institutions in Taiwan have set forth to provide clinical consensus guidelines on the management of CAT, based on local clinical practices and guided by predominant international clinical practice guidelines. This paper aims to describe the current disease burden of cancer-associated venous thromboembolism in Taiwanese cancer patients, and discusses the unmet needs and gaps in the management of this medical complication. It also outlines diagnostic and management strategies relevant to the different treatment options available, such as non-vitamin K antagonist oral anticoagulants.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999188 | PMC |
| http://dx.doi.org/10.6515/ACS.202303_39(2).20220719A | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!